Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

Similar documents
Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers

Prescription Monitoring Program (PMP)

Special SEOW Report: Behavioral Health Among Women in Maine

The Opioid Crisis: Effectiveness of State Responses

Opioid Use and Other Trends

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

2016 Dr. Douglas H. Kay CPE Symposium

Medicaid and the Opioid Crisis

Update on Maine Laws and Associated Rules on Prescribing Opioid Medication

Opioid Overview Admiral Brett P. Giroir, M.D.

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

Successful Prevention Strategies to Address the Opioid Crises

Combating the Opiate Crisis in Ohio

How serious is the opiate problem in Fairfield County?

Targeting an Epidemic: Opioid Prescribing Patterns by County in New York State

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

SUBSTANCE EXPOSED NEWBORNS

Opioid Overdose in Oregon Report to the Legislature

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

Update on Maine Laws and Associated Rules on Prescribing Opioid Medication

Substance Use Disorders: A Path Forward for Michigan

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)

Opioid Task Force Kick-Off Meeting. February 29, 2016

White Paper on. Prescription Drug Abuse

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

PRESCRIBING GUIDELINES

Mental and Behavioral Health

Child Welfare and MOMS: Building Partnerships to Improve Care

Illicit Opioid and Methamphetamine Trends in Maine

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

Progress Report Maine Opiate Collaborative Recommendations. on the. October 2018

Opioid Abuse Treatment in Pregnancy

What is the strategy?

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

The Opioid Crisis among the Privately Insured

2/20/2019. Source: Source:

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Caring for ME Lunch & Learn Webinar Opioid Prescribing Regulations Updates on Chapter 488 and Related Rules

Blue Cross of Idaho Addresses State s Opioid Issue

Strategies to Manage The Opioid Crisis

Aetna s Initiative on the Opioid Epidemic

GOALS AND OBJECTIVES

Opioid Prescription and Illicit Drug Overdoses: On the Rise

C.A.A.R.E. WCPA/WPLF 2016 Winter Conference 4/5/2018. Greenfield Prior to C.A.A.R.E. Cops Assisting Addiction Recovery. Greenfield Police Department

The Opioid Epidemic and PerformRx s Approach to Address It: A Collaborative Model with PBM, Payor and Behavioral Health

DHHS Vision & Priorities for the Future. M3 Conference NC Medical Society September 15, 2017

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

OHIO LEGISLATIVE SERVICE COMMISSION

Opioid Addiction Statistics

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Opioid Response Package Awaits President s Signature Trinity Tomsic

Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges

Opioid State Targeted Response (STR) Project

Do your Part Be the Solution

But like others, we were initially fighting pill mills. Orange County worked to outlaw them and to provide resources for breaking opioid addiction.

Opioid Management of Chronic (Non- Cancer) Pain

Stark County Opiate Task Force

New Jersey Department of Human Services Division of Mental Health and Addiction Services

Medication-Assisted Treatment. What Is It and Why Do We Use It?

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

State Opioid Response (SOR) Grant

Subject: New Jersey A Na+onal Leader In The Fight Against The Opioid Epidemic Tuesday, September 19, 2017 at 12:05:35 PM Eastern Daylight Time

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

Improving care for pregnant people with opioid use disorder in U.S. jails: Research to implement medication assisted treatment

MAT in the Corrections Setting

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

TN Opioid Program. Erica Schlesinger, Pharm.D

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Community Response Addressing The Opioid Crisis. Leon, Wakulla, Gadsden, Franklin, Liberty, Jefferson, Madison and Taylor Counties

Medicaid s Role in Combating the Opioid Crisis

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

Corporate Medical Policy

Lorain County Community Health Improvement Plan Annual report

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

From Medicaid Transformation Approved Project Toolkit, June 2017

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

OPQC Learning Session: High Risk Moms & Infants. Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Fighting Today s Opioid Epidemic

Addressing the Opioid Crisis Policy Recommendations

Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Transcription:

Maine s Response to the Opiate Crisis Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

Required Disclosure Text Font typically Times New Roman at least 20 point Try to have size consistent throughout Department of Health and Human Services 2

Unintentional Injury Deaths in Maine, By Type: 2009-2014 In 2014, there were 208 drug-related overdose deaths compared to 131 motor vehiclerelated deaths. 208 131 Source: Office of the Chief Medical Examiner, Maine Bureau of Highway Safety/Maine Department of Transportation Department of Health and Human Services 3

Number of Drug Deaths in Maine Involving Specific Drug Types*: 2014** In 2014, more than one in three overdose deaths involved benzodiazepines. More than one in four overdose deaths involved heroin/morphine. *Some deaths may be caused by more than one key drug. **2014 results are preliminary ***Deaths caused by known pharmaceutical morphine removed from total. Source: Marci Sorg, Margaret Chase Smith Policy Center at University of Maine, Office of the Chief Medical Examiner Department of Health and Human Services 4

Heroin-Related Death Overdoses, Maine vs. Nation: 2002-2013 Source, National Data: USCDC; Multiple Cause of Death Files from the National Vital Statistics System, 2002-2013. Source, Maine Data: Maine Department of Health and Human Services, Office od Research, Data and Vital Statistics Department of Health and Human Services 5

Number of Drug Affected Baby Notifications* in Maine: 2005-2014 In 2014, there were a total of 976reports of drug affected babies and 995 in 2015. From 2005 to 2014, the number of drug affected baby notifications increased by 480%. *This measure reflects the number of infants born in Maine where a healthcare provider reported to OCFS that there was reasonable cause to suspect the baby may be affected by illegal substance abuse or demonstrating withdrawal symptoms resulting from prenatal drug exposure (illicit or prescribed appropriately under a physician s care for the mother s substance abuse treatment) or who have fetal alcohol spectrum disorders. Source: Office of Child and Family Services (OCFS), Maine Automated Child Welfare Information System Department (MACWIS). of Health and Human Services 6

Additional Facts.. Maine is the #1 state in per capita long acting/extended release opioid prescriptions (USCDC, 2012). In 2014, more than 80 million opioid pills were prescribed in Maine. Studies have shown that greater than 75% of heroin users utilized prescription painkillers as their gateway. Department of Health and Human Services

Substance Abuse Treatment Spending in Maine In 2015, Maine spent more than $70 million on substance abuse treatment, an increase of 25% since 2008. Spending (in Thousands) Department of Health and Human Services 8

Maine Spending Per Capita Maine s per capita and GDP spending on substance abuse treatment is higher than the national average and greater than many of our counterparts in the Northeast. Note: This data reflects spending by the State Substance Abuse agencies only. It does not include Medicaid expenditures. Source: The Pew Charitable Trusts and the John D. and Catherine T. MacArthur Foundation; Substance Use Disorders and the Role of the States; March 2015. Based on 2013 data. Department of Health and Human Services 9

PL c. 488 Background In March 2016, under the LePage Administration, a bill was introduced and ultimately passed to combat Maine s opiate crisis. PL 2016, Chapter 488, An Act to Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program was passed in April 2016, and went into effect July 29, 2016. Department of Health and Human Services 10

Prescription Limits Morphine Milligram Equivalents (MMEs) Applies to new opioid patients, effective July 29, 2016 May not prescribe any combination of opioid medication in an aggregate amount of more than 100 MMEs per day Existing opioid patients with active prescription in excess of 100 MMEs per day as of July 2016 ( legacy patients ) From effective date of law until July 1, 2017, may not prescribe any combination of opioid medication in an aggregate amount of more than 300 MMEs per day Exceptions are granted for medical necessity that is documented in the medical record until January 1, 2017, or the effective date of the DHHS rulemaking on exceptions, whichever is later Department of Health and Human Services 11

Prescription Limit Exceptions When prescribing for: Active or aftercare cancer treatment Palliative care End-of-life hospice care Medication-assisted treatment for substance abuse disorder When directly ordered or administered in: An emergency department An inpatient hospital A long-term care or residential care facility Department of Health and Human Services 12

Prescription Limits for Opioid Medications Acute Pain Script may not be written for more than a 7-day supply Chronic Pain Script may not be written for more than a 30-day supply Department of Health and Human Services 13

http://agencymeddirectors.wa.gov/calculator/dosecalculator.htm

Prescriber Responsibilities Required PMP check as of January 1, 2017 Upon initial prescription of benzodiazepine or opioid medication Every 90 days thereafter for chronic prescriptions Exception A PMP check is not required for benzodiazepine or opioid medication that is directly administered in an emergency room, an inpatient hospital, a long-term care facility or a residential care facility Department of Health and Human Services 16

Prescriber Responsibilities Electronic Prescribing as of July 1, 2017 All prescribers with the capability to electronically prescribe must prescribe opioid medication electronically A waiver may be available in some circumstances Continuing Education as of December 31, 2017 A prescriber must complete three hours of CME on the prescription of opioid medication every two years as a condition of prescribing opioid medication Department of Health and Human Services 17

Other DHHS Initiatives: 2-1-1 Maine DHHS, in coordination with 2-1-1, has established a 24/7 resources line for individuals struggling with addiction. Line provides a direct referral and warm hand-off to appropriate services. With more than 1,000 babies born drug-affected every year, DHHS has placed a particular focus on supporting pregnant moms through this resource line. Department of Health and Human Services 18

Other DHHS Initiatives: Medication Assisted Therapies Medication-assisted therapies (MATs) (e.g., methadone, Suboxone) must be comprehensive and treatment must be held to the same clinical standards as other chronic conditions. Maine DHHS has promulgated new Medicaid rules for MAT to help ensure appropriate behavioral health services are utilized, a comprehensive treatment plan is developed and adhered to, and that individuals not succeeding with their current treatment modality move to another treatment modality. Department of Health and Human Services 19

Other DHHS Initiatives: Medication Assisted Therapies Vivitrol, a MAT that suppresses the effects of opioid addiction by eliminating withdrawal symptoms, can help keep a person with substance abuse disorder from relapsing. Maine has developed a pilot that will provide monthly Vivitrol injections and therapy to more than 600 individuals over the next three years. The target populations for the pilot are youth, young moms who have been involved in the criminal justice system and individuals currently incarcerated to help them maintain abstinence upon release. Department of Health and Human Services 20

Other DHHS Initiatives: Serving the Uninsured The Office of Substance Abuse and Mental Health Services (SAMHS) funds more than $20,000,000 in substance abuse treatment and prevention services for the uninsured. Additionally, SAMHS is reforming the payment structure for the uninsured to focus spending directly on the individual with substance abuse disorder. Department of Health and Human Services 21

Other DHHS Initiatives: Protecting Kids More than 60% of the children coming into the State s protective custody is due to parental substance abuse as a risk factor. DHHS has launched an innovative pilot designed to support vulnerable and at-risk families by co-locating parenting education and substance abuse services. At least 250 eligible parents will receive coordinated, concurrent and co-located parent education and substance abuse treatment services. Department of Health and Human Services 22

Questions? Dr. Christopher Pezzullo State Health Officer christopher.pezzullo@maine.gov Department of Health and Human Services 23